Drugs

Public Notification: Dynamizm Capsules contain hidden drug ingredient

[3-17-2016] The Food and Drug Administration (FDA) is advising consumers not to purchase or use Dynamizm Capsules, a product promoted and sold for weight loss on various websites and possibly in some retail stores.Image of Dynamizm Capsules 

 
FDA laboratory analysis confirmed that Dynamizm Capsules contain sibutramine. Sibutramine is a controlled substance that was removed from the market in October 2010 for safety reasons. The product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This product may also interact, in life-threatening ways, with other medications a consumer may be taking.
 
Health care professionals and patients are encouraged to report adverse events or side effects related to the use of this product to FDA's MedWatch Safety Information and Adverse Event Reporting Program:
 

Note: This notification is to inform the public of a growing trend of dietary supplements or conventional foods with hidden drugs and chemi

cals. These products are typically promoted for sexual enhancement, weight loss, and body building and are often represented as being “all natural.” FDA is unable to test and identify all products marketed as dietary supplements that have potentially harmful hidden ingredients. Consumers should exercise caution before purchasing any product in the above categories. 

 
For more information:
 
 
 

 

Contact FDA

Toll Free
(855) 543-3784, or
(301) 796-3400
Human Drug Information

Division of Drug Information (CDER)

Office of Communications

Feedback Form

10001 New Hampshire Avenue

Hillandale Building, 4th Floor

Silver Spring, MD 20993

Page Last Updated: 03/17/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.